CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $12.12B, above the global median of $1.18B
- Interpretations6 currently firing — 6
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
12.12BUSDvs all stocks (USD)
Revenue (TTM)
431.80MUSDvs all stocks (USD)
Profit Margin
-31.66%Beta
2.22xvs all stocks
52-Week Change
565.47%vs all stocks
Market Capitalization
12.12BUSDvs all stocks (USD)
Enterprise Value
11.41BUSDvs all stocks (USD)
Forward P/E
-289.06xPrice to Sales (TTM)
28.07xPrice to Book (MRQ)
25.71xEnterprise to Revenue
26.42xEnterprise to EBITDA
-98.94xGross Margin
52.76%Profit Margin
-31.66%Operating Margin
-30.65%Return on Assets (TTM)
-13.09%Return on Equity (TTM)
-29.59%Revenue (TTM)
431.80MUSDvs all stocks (USD)
Revenue per Share (TTM)
7.03USDUpdated Sep 28, 2026Quarterly Revenue Growth
23.20%Gross Profit (TTM)
224.38MUSDvs all stocks (USD)
EBITDA (TTM)
-115.28MUSDvs all stocks (USD)
Net Income (TTM)
-136.72MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
23.24%Operating Cash Flow (TTM)
-53.07MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-64.82MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
376.57MUSDFY2025 · Sep 30, 2025Cost of Goods Sold
185.57MUSDFY2025 · Sep 30, 2025Gross Profit
191.00MUSDFY2025 · Sep 30, 2025Operating Income
-136.26MUSDvs all stocks (USD)
Pre-tax Income
-76.95MUSDFY2025 · Sep 30, 2025Income Tax Expense
719.00KUSDFY2025 · Sep 30, 2025Net Income
-77.67MUSDFY2025 · Sep 30, 2025EBIT
-136.26MUSDFY2025 · Sep 30, 2025EBITDA (Income Statement)
-160.25MUSDFY2025 · Sep 30, 2025Research & Development
80.28MUSDFY2025 · Sep 30, 2025Selling, General & Administrative
246.98MUSDFY2025 · Sep 30, 2025Non-operating Interest Income
11.36MUSDFY2025 · Sep 30, 2025EPS (Basic)
-1.30USDFY2025 · Sep 30, 2025EPS (Diluted)
-1.30USDFY2025 · Sep 30, 2025Basic Shares Outstanding
59.81MSharesFY2025 · Sep 30, 2025Diluted Shares Outstanding
59.81MSharesFY2025 · Sep 30, 2025Net Income from Continuing Operations
-77.67MUSDFY2025 · Sep 30, 2025Operating Cash Flow
1.59MUSDFY2025 · Sep 30, 2025Free Cash Flow
-26.41MUSDFY2025 · Sep 30, 2025Cash & Cash Equivalents (End of Period)
185.43MUSDFY2025 · Sep 30, 2025Income Tax Paid
683.00KUSDFY2025 · Sep 30, 2025Starting Profit (CF Statement)
-77.67MUSDFY2025 · Sep 30, 2025Depreciation & Amortization
24.85MUSDFY2025 · Sep 30, 2025Stock-based Compensation
64.46MUSDFY2025 · Sep 30, 2025Other Non-cash Items
2.18MUSDFY2025 · Sep 30, 2025Change in Accounts Receivable (CF)
-22.38MUSDFY2025 · Sep 30, 2025Change in Accounts Payable (CF)
9.33MUSDFY2025 · Sep 30, 2025Change in Other Assets/Liabilities
815.00KUSDFY2025 · Sep 30, 2025Capital Expenditures
-28.00MUSDFY2025 · Sep 30, 2025Net Acquisitions
2.50MUSDFY2025 · Sep 30, 2025Purchase of Investments
-49.39MUSDFY2025 · Sep 30, 2025Sale of Investments
50.13MUSDFY2025 · Sep 30, 2025Net Investing Cash Flow
-24.76MUSDFY2025 · Sep 30, 2025Common Stock Repurchase
-16.00KUSDFY2025 · Sep 30, 2025Other Financing Charges
15.00MUSDFY2025 · Sep 30, 2025Net Financing Cash Flow
14.98MUSDFY2025 · Sep 30, 2025Shares Outstanding
62.67MSharesUpdated Sep 28, 2026Float Shares
61.96MSharesUpdated Sep 28, 2026Shares Short
12.51MSharesUpdated Sep 28, 2026Short Ratio
7.74daysvs all stocks
Short % of Shares Outstanding
23.79%vs all stocks
% Held by Insiders
0.77%vs all stocks
% Held by Institutions
116.90%vs all stocks
Total Cash (MRQ)
166.84MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.66USDUpdated Sep 28, 2026Total Debt (MRQ)
108.59MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.2436xCurrent Ratio (MRQ)
2.67xBook Value per Share (MRQ)
7.11USDUpdated Sep 28, 2026Total Assets
641.86MUSDvs all stocks (USD)
Total Current Assets
332.97MUSDFY2025 · Sep 30, 2025Total Liabilities
168.90MUSDFY2025 · Sep 30, 2025Total Non-current Assets
308.89MUSDFY2025 · Sep 30, 2025Total Non-current Liabilities
77.50MUSDFY2025 · Sep 30, 2025Total Current Liabilities
91.41MUSDFY2025 · Sep 30, 2025Cash
32.68MUSDFY2025 · Sep 30, 2025Cash Equivalents
150.37MUSDFY2025 · Sep 30, 2025Cash & Cash Equivalents
183.05MUSDFY2025 · Sep 30, 2025Other Short-term Investments
49.38MUSDFY2025 · Sep 30, 2025Accounts Receivable
57.02MUSDFY2025 · Sep 30, 2025Inventory
28.31MUSDFY2025 · Sep 30, 2025Accounts Payable
11.09MUSDFY2025 · Sep 30, 2025Short-term Debt
13.82MUSDFY2025 · Sep 30, 2025Deferred Revenue
6.88MUSDFY2025 · Sep 30, 2025Other Current Liabilities
722.00KUSDFY2025 · Sep 30, 2025Long-term Debt
61.75MUSDFY2025 · Sep 30, 2025Other Non-current Liabilities
747.00KUSDFY2025 · Sep 30, 2025Common Stock (Book)
0.00USDFY2025 · Sep 30, 2025Retained Earnings
-1.32BUSDFY2025 · Sep 30, 2025Total Shareholders' Equity
472.96MUSDvs all stocks (USD)
52-Week Low
23.30USDUpdated Sep 28, 202652-Week High
187.44USDUpdated Sep 28, 202652-Week Change
565.47%vs all stocks
Beta
2.22xvs all stocks
50-Day MA
126.28USDUpdated Sep 28, 2026200-Day MA
73.17USDUpdated Sep 28, 2026Avg 10-Day Volume
2.49MSharesUpdated Sep 28, 2026Avg 30-Day Volume
1.89MSharesUpdated Sep 28, 2026Diluted EPS (TTM)
-2.23USDUpdated Sep 28, 2026Other Income / Expense
47.94MUSDFY2025 · Sep 30, 20256 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
Debt Falling While Share Count Rises
Debt has fallen for four years while the share count rose over eight.
Reads
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
How does this company use capital?
Diagnostic
Operating Cash Flow Rising While Current Assets Shrink
Operating cash flow has trended up for six years while the current assets behind it shrank.
Reads
Diagnostic
Depreciation-Heavy Reported Profit
It reports a profit, and much of the gap to cash is depreciation rather than earnings.
Reads
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Is this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.53Profit Margin: -0.32
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $12.12B, above the global median of $1.18BNotable
Market cap (USD): 12,121,843,642Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Baxter International Inc.
Tier 1ProductionThroughput-Bound ConversionRule
Encompass Health Corporation
Tier 1ProductionThroughput-Bound ConversionRuleFlow
China Resources Microelectronics Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Tata Power Company Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sanmina Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRisk
SSAB AB ser. A
Tier 1ProductionThroughput-Bound ConversionFlowRule
China Shipbuilding Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
National Silicon Industry Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Nexchip Semiconductor Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Shannon Semiconductor Tech Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Iovance Biotherapeutics, Inc.
2 interpretationsHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBCMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Suzhou Novoprotein Scientific Co., Ltd.
1 interpretationMulti-Year Debt Decrease With Cash Near Total Debt And Equity